BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30893501)

  • 1. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
    Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
    Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
    Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
    J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.
    Shah S; Dalecki AG; Malalasekera AP; Crawford CL; Michalek SM; Kutsch O; Sun J; Bossmann SH; Wolschendorf F
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5765-76. PubMed ID: 27431227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Antimycobacterial Activity of 3-Phenyl-1
    Jardim Etchart R; Rambo RS; Lopes Abbadi B; Sperotto N; Ev Neves C; Fries Silva F; Dornelles M; Duarte L; Souza Macchi F; Alberton Perelló M; Vescia Lourega R; Valim Bizarro C; Basso LA; Machado P
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents.
    Kesicki EA; Bailey MA; Ovechkina Y; Early JV; Alling T; Bowman J; Zuniga ES; Dalai S; Kumar N; Masquelin T; Hipskind PA; Odingo JO; Parish T
    PLoS One; 2016; 11(5):e0155209. PubMed ID: 27171280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
    Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
    Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
    Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
    PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel (-)-Camphene-based thiosemicarbazones and evaluation of anti-
    Souza MRP; Coelho NP; Baldin VP; Scodro RBL; Cardoso RF; da Silva CC; Vandresen F
    Nat Prod Res; 2019 Dec; 33(23):3372-3377. PubMed ID: 29792346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis.
    Segretti ND; Simões CK; Corrêa MF; Felli VMA; Miyata M; Cho SH; Franzblau SG; Fernandes JPDS
    Tuberculosis (Edinb); 2016 Jul; 99():11-16. PubMed ID: 27449999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
    Chandrasekera NS; Alling T; Bailey MA; Files M; Early JV; Ollinger J; Ovechkina Y; Masquelin T; Desai PV; Cramer JW; Hipskind PA; Odingo JO; Parish T
    J Med Chem; 2015 Sep; 58(18):7273-85. PubMed ID: 26295286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
    Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.